據(jù)悉，陶氏化學(xué)已經(jīng)達(dá)成一項(xiàng)收購(gòu)協(xié)議，計(jì)劃以約1.4億美元現(xiàn)金的價(jià)格收購(gòu)科慕公司位于得克薩斯州博蒙特的苯胺生產(chǎn)設(shè)施。據(jù)IHS化學(xué)估計(jì)，科慕公司得州博蒙特苯胺生產(chǎn)設(shè)施的產(chǎn)能為17.2萬(wàn)噸/年。該交易預(yù)計(jì)在2016年一季度完成。

　　陶氏化學(xué)表示：“此次收購(gòu)將允許公司將苯胺業(yè)務(wù)集成到北美的MDI產(chǎn)業(yè)鏈中，這樣可以改善成本競(jìng)爭(zhēng)力、減少贏利波動(dòng)以及為陶氏聚氨酯業(yè)務(wù)未來(lái)增長(zhǎng)提供苯胺技術(shù)。”

　　龐曉華摘譯自《Chemical Week》2015-11-19

　　原文如下：

　　Dow Chemical to acquire Chemours' Beaumont, TX aniline unit $140 million

　　7:44 AM MST | November 19, 2015 | Robert Westervelt

　　Dow Chemical has reached agreement to acquire Chemours' aniline facility in Beaumont, TX for approximately $140 million in cash. The Beaumont, TX facility has aniline capacity of 172,000 m.t./year, according to IHS Chemical estimates. The deal is expected to close in first-quarter 2016.

　　"This acquisition allows Dow to integrate aniline into its MDI value chain in North America, thereby improving cost competitiveness, reducing earnings volatility, and providing access to aniline technology for future growth in Dow’s valuable polyurethanes business," Dow says.